Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma

被引：0
|
作者：
Hongyan Huang
Meifang He
Yanbin Zhang
Bo Zhang
Zubiao Niu
You Zheng
Wen Li
Peilin Cui
Xiaoning Wang
Qiang Sun
机构：
[1] Beijing Shijitan Hospital of Capital Medical University,Department of Oncology
[2] Sun Yat-Sen University,Laboratory of General Surgery, The First Affiliated Hospital
[3] Institute of Biotechnology,Laboratory of Cell Engineering
[4] Beijing Tiantan Hospital of Capital Medical University,Department of Gastroenterology
来源：
Signal Transduction and Targeted Therapy | / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma
    Huang, Hongyan
    He, Meifang
    Zhang, Yanbin
    Zhang, Bo
    Niu, Zubiao
    Zheng, You
    Li, Wen
    Cui, Peilin
    Wang, Xiaoning
    Sun, Qiang
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [2] Serum calcium level used as a prognostic predictor in patients with resectable pancreatic ductal adenocarcinoma
    Dong, Qian
    Zhang, Yao
    Yang, Xiang-hong
    Jing, Wei
    Zheng, Li-qiang
    Liu, Yun-peng
    Qu, Xiu-juan
    Li, Zhi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2014, 38 (05) : 639 - 648
  • [3] Serum aspartate aminotransferase is an adverse prognostic indicator for patients with resectable pancreatic ductal adenocarcinoma
    He, Meifang
    Liu, Yin
    Huang, Hefei
    Wu, Jiali
    Wu, Juehui
    Wang, Ruizhi
    Wang, Dong
    LABORATORY MEDICINE, 2023, 54 (06) : 608 - 612
  • [4] Homotypic cell-in-cell structures as an adverse prognostic predictor of hepatocellular carcinoma
    Wang, Ruizhi
    Zhu, Yichao
    Zhong, Hao
    Gao, Xinyue
    Sun, Qiang
    He, Meifang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma
    Shuai Xu
    Xiu-Ping Zhang
    Guo-Dong Zhao
    Wen-Bo Zou
    Zhi-Ming Zhao
    Qu Liu
    Ming-Gen Hu
    Rong Liu
    Hepatobiliary&PancreaticDiseasesInternational, 2023, 22 (02) : 160 - 168
  • [6] Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma
    Xu, Shuai
    Zhang, Xiu-Ping
    Zhao, Guo-Dong
    Zou, Wen-Bo
    Zhao, Zhi-Ming
    Liu, Qu
    Hu, Ming-Gen
    Liu, Rong
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (02) : 160 - 168
  • [7] Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma
    Iuga, Cristina
    Seicean, Andrada
    Iancu, Cornel
    Buiga, Rares
    Sappa, Praveen K.
    Voelker, Uwe
    Hammer, Elke
    PROTEOMICS, 2014, 14 (7-8) : 945 - 955
  • [8] Subtyped cell-in-cell structures associate with patient survival of human pancreatic ductal adenocarcinoma
    He, M.
    Huang, H.
    Wang, X.
    Sun, Q.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 602 - 603
  • [9] Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma
    Izumo, Wataru
    Higuchi, Ryota
    Furukawa, Toru
    Yazawa, Takehisa
    Uemura, Shuichirou
    Shiihara, Masahiro
    Yamamoto, Masakazu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 780 - 786
  • [10] Prognostic Impact of Time to Surgery in Patients With Resectable Pancreatic Ductal Adenocarcinoma
    Joliat, Gaetan-Romain
    Labgaa, Ismail
    Gilgien, Jerome
    Demartines, Nicolas
    PANCREAS, 2021, 50 (01) : 104 - 110
12345